Peeken Lab

Research focus

ERC Starting Grant · 2025

Artificial intelligence-based personalized and interactive radiotherapy target definition for enhanced cancer care

Cancer is the second leading cause of death globally, with radiotherapy (RT) being a cornerstone treatment for nearly half of all patients. A key element of RT is the accurate definition of target volumes, a task traditionally performed manually by physicians. The quality of target volumes differs significantly between treatment centers and healthcare systems, directly impacting patients’ outcomes. While advances in artificial intelligence (AI) have simplified and standardized the segmentation of healthy organs, creating personalized target volumes that incorporate individual patient-specific data remains an unsolved challenge. AI-PIONEER aims to revolutionize the RT treatment planning…

From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.